VIE/MRCK (VIE/MRCK)

Vienna Stock Exchange: VIE/MRCK · EUR

€147

+3.50 (+2.4%)· Recorded snapshot

Market cap	63.5B
Revenue (ttm)	21.1B
Net income (ttm)	2.4B
EPS (ttm)	€5.45
P/E (trailing)	26.9x
P/E (forward)	16.7x
Dividend	€2.20 (1.50%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 21.1B
Net income (ttm): 2.4B
EPS (ttm): €5.45
P/E (trailing): 26.9x
P/E (forward): 16.7x
Market cap: 63.5B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 19:55 UTC

Forward P/E16.7

P25 n/aP50 n/aP75 n/a

Trailing P/E26.9

P25 n/aP50 n/aP75 n/a

ROE8.1

P25 n/aP50 n/aP75 n/a

ROIC7.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All VIE/MRCK indicators

Market & fundamental data

Available fields

236

Groups with data

Currency

EUR

Showing 236 of 236 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Germany
Country code	AT
Earnings date	2026-11-12
Employees	62,136
Employees change	91
Employees growth	0.15%
Enterprise value	EUR 72.8B
Exchange	Vienna Stock Exchange
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1668
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
ISIN number	DE0006599905
Last earnings date	2026-08-06
Last refreshed	2026-10-29
Market cap	EUR 63.5B
Next earnings date	2026-11-12
Price	EUR 146.60
Price currency	EUR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	vie/MRCK
Website	https://www.merckgroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	22.9x
Average P/E ratio (3Y)	21.94x
Average P/E ratio (5Y)	23.09x
Earnings yield	3.72%
EV/Earnings	30.71x
EV/EBIT	19.56x
EV/EBITDA	13.03x
EV/FCF	26.72x
EV/Sales	3.44x
FCF / EV yield	3.74%
FCF yield	4.29%
Forward P/E	16.66x
Graham number	92.78089
Graham upside	-36.71%
Lynch fair value	EUR 27.36
Lynch upside	-81.34%
P/B ratio	2.1x
P/E ratio	26.9x
P/FCF ratio	23.31x
P/OCF ratio	15x
P/S ratio	3x
Price / tangible book value	15.27x
Price/EBITDA ratio	11.37x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	17.61%
EBITDA margin	26.43%
Effective tax rate	21.35%
FCF margin	12.89%
Gross margin	59.09%
Operating margin	17.61%
Pretax margin	14.34%
Profit margin	11.21%
Profit per employee	EUR 38,142
Profitable quarters	56
Profitable years	24
Revenue per employee	EUR 340,141
ROA	4.65%
ROA (5Y)	5.55%
ROCE	8.35%
ROE	8.13%
ROE (5Y)	11.9%
ROIC	7.55%
ROIC (5Y)	10.07%
Tax / revenue	3.06%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-17.27%
EPS growth (Q)	-24.67%
EPS growth (QoQ)	-25.66%
EPS growth 10Y	5.48%
EPS growth 3Y	-8.35%
EPS growth 5Y	-2.79%
EPS growth years	0
FCF growth	25.94%
FCF growth (Q)	30.34%
FCF growth (QoQ)	-4.58%
FCF growth 3Y	5.5%
FCF growth 5Y	-2.68%
Gross profit growth	0.26%
Gross profit growth (Q)	4.59%
Gross profit growth 3Y	-2.67%
Gross profit growth 5Y	1.67%
Net income growth	-17.22%
Net income growth (Q)	-24.85%
Net income growth (QoQ)	-25.69%
Net income growth 3Y	-8.34%
Net income growth 5Y	-2.81%
Net income growth years	0
OCF growth	10.99%
OCF growth (Q)	6.7%
OCF growth (QoQ)	-26.04%
OCF growth 10Y	6.51%
OCF growth 3Y	1.54%
OCF growth 5Y	-1.49%
Operating income growth	-15.12%
Operating income growth (Q)	-15.49%
Operating income growth 3Y	-7.02%
Operating income growth 5Y	-1.75%
Revenue growth	-0.4%
Revenue growth (Q)	3.41%
Revenue growth (QoQ)	5.85%
Revenue growth 10Y	4.16%
Revenue growth 3Y	-1.42%
Revenue growth 5Y	2.65%
Revenue growth quarters	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -1.5B
Depreciation and amortization	EUR 1.9B
EBIT	EUR 3.7B
EBITDA	EUR 5.6B
EPS	EUR 5.45
Financing cash flow	EUR 1.6B
Free cash flow	EUR 2.7B
Gross profit	EUR 12.5B
Income taxes	EUR 647M
Investing cash flow	EUR -5.1B
Net borrowing	EUR 2.7B
Net cash flow	EUR 789M
Net income	EUR 2.4B
Operating income	EUR 3.7B
Revenue	EUR 21.1B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.79
Book value per share	EUR 69.58
Debt / EBITDA	2.2
Debt / equity	0.41
Debt / FCF	4.52
Goodwill	EUR 18.5B
Interest coverage	9.08
Long-term assets	EUR 38.9B
Long-term liabilities	EUR 14.3B
Net cash (debt)	EUR -9.2B
Net cash / market cap	-14.46%
Net debt / EBITDA	1.64
Net debt / equity	0.3
Net debt / FCF	3.37
Piotroski F-Score	6
Property, plant and equipment	EUR 10.1B
Shareholders' equity	EUR 30.3B
Tangible book value	EUR 4.2B
Tangible book value per share	EUR 9.59
Total assets	EUR 52.7B
Total cash	EUR 3.1B
Total debt	EUR 12.3B
Total liabilities	EUR 22.4B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.42
Current assets	EUR 13.8B
Current liabilities	EUR 8.1B
Current ratio	1.69
Inventory turnover	1.85
Net working capital	EUR 3.6B
Quick ratio	0.99
Working capital	EUR 5.6B
Working capital turnover	5.3

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0%
Dividend growth	0%
Dividend growth (3Y)	0%
Dividend growth (5Y)	9.46%
Dividend growth years	0
Dividend payment date	2026-04-29
Dividend payment years	10
Dividend payout frequency	Annual
Dividend per share	EUR 2.20
Dividend yield	1.5%
Ex-dividend date	2026-04-27
Last dividend	EUR 2.20
Payout ratio	43.8%
Shareholder yield	1.5%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 132.14
1D price change	2.45%
1M price change	7.76%
1M total return	7.76%
1W price change	0.89%
1W total return	0.89%
1Y price change	27.7%
1Y return CAGR	30.29%
1Y total return	30.27%
20-day SMA	EUR 141.23
200-day SMA	EUR 129.20
3M price change	3.39%
3M total return	3.39%
3Y price change	2.48%
3Y return CAGR	2.61%
3Y total return	8.03%
50-day SMA	EUR 137.86
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 147.50
52-week high date	2026-08-06
52-week low	EUR 100.60
52-week low date	2026-03-23
5Y price change	-27.5%
5Y return CAGR	-4.78%
5Y total return	-21.7%
6M price change	34.74%
6M total return	34.74%
All-time high	EUR 231.20
All-time high date	2021-12-28
All-time low	EUR 74.82
All-time low date	2018-03-26
Average true range (ATR)	EUR 2.20
Average volume	3.7
Change from 52-week high	-0.61%
Change from 52-week low	45.73%
Change from all-time high	-36.59%
Change from all-time low	95.94%
Change from open	0.24%
Day's gap	2.2%
High price	EUR 146.60
Low price	EUR 145.05
Monthly RSI	56.33
Open price	EUR 146.25
Position in 52-week range	100%
Previous close	EUR 143.10
Price vs 150-day SMA	10.94%
Price vs 20-day SMA	3.81%
Price vs 200-day SMA	13.46%
Price vs 50-day SMA	6.34%
Relative volume	10.58
RSI	63.79
Sharpe ratio	0.99
Sharpe ratio (3Y)	0.07
Sharpe ratio (5Y)	-0.21
Sortino ratio	1.73
Sortino ratio (3Y)	0.32
Sortino ratio (5Y)	-0.09
Weekly RSI	62.42
YTD price change	20.12%
YTD total return	22.53%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	129.2M
Shares change (QoQ)	-0.04%
Shares change (YoY)	0%
Shares held by institutions	14.19%

Deeper analysis on VIE/MRCK

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/MRCK report

Is a complete VIE/MRCK research report available?

No complete published report is available for vie/MRCK (VIE/MRCK) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/MRCK (VIE/MRCK)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/MRCK

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/MRCK indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/MRCK

Frequently asked questions